Cargando…

Target Selection of Directional Lead in Patients with Parkinson’s Disease

Several structures including subthalamic nucleus (STN), the caudal zona incerta (cZI), the prelemniscal radiation (Raprl), and the thalamic ventral intermediate nucleus (Vim) have been reported to be useful for improving symptoms of Parkinson’s disease (PD). However, the effect of each target is sti...

Descripción completa

Detalles Bibliográficos
Autores principales: SASAGAWA, Ayaka, ENATSU, Rei, KITAGAWA, Mayumi, MIKAMI, Takeshi, NAKAYAMA-KAMADA, Chie, KURIBARA, Tomoyoshi, HIRANO, Tsukasa, ARIHARA, Masayasu, MIKUNI, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803701/
https://www.ncbi.nlm.nih.gov/pubmed/33162470
http://dx.doi.org/10.2176/nmc.tn.2020-0210
_version_ 1783635999002198016
author SASAGAWA, Ayaka
ENATSU, Rei
KITAGAWA, Mayumi
MIKAMI, Takeshi
NAKAYAMA-KAMADA, Chie
KURIBARA, Tomoyoshi
HIRANO, Tsukasa
ARIHARA, Masayasu
MIKUNI, Nobuhiro
author_facet SASAGAWA, Ayaka
ENATSU, Rei
KITAGAWA, Mayumi
MIKAMI, Takeshi
NAKAYAMA-KAMADA, Chie
KURIBARA, Tomoyoshi
HIRANO, Tsukasa
ARIHARA, Masayasu
MIKUNI, Nobuhiro
author_sort SASAGAWA, Ayaka
collection PubMed
description Several structures including subthalamic nucleus (STN), the caudal zona incerta (cZI), the prelemniscal radiation (Raprl), and the thalamic ventral intermediate nucleus (Vim) have been reported to be useful for improving symptoms of Parkinson’s disease (PD). However, the effect of each target is still unclear. Therefore, we investigated each structure’s effects and adverse effects using a directional lead implanted in the posterior STN adjacent to the cZI and Raprl in two patients with tremor-dominant PD. In Case 1, maximal reduction of tremor was obtained by stimulation toward the Vim, and stimulation toward the thalamic reticular nucleus (TRN) reduced verbal fluency, but did not induce dysarthria. In Case 2, maximal reduction of tremor was obtained by stimulation toward the dorsal STN and Raprl. Maximal reduction of rigidity was achieved by stimulation toward the dorsal STN, Raprl, and cZI. Bradykiensia was improved by stimulation in all directions, but dyskinesia and dysarthria were evoked by stimulation toward the dorsal STN and cZI. The directional lead may elucidate the stimulation effect of each structure and broaden target selection depending on patients’ symptoms and adverse effects.
format Online
Article
Text
id pubmed-7803701
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japan Neurosurgical Society
record_format MEDLINE/PubMed
spelling pubmed-78037012021-01-14 Target Selection of Directional Lead in Patients with Parkinson’s Disease SASAGAWA, Ayaka ENATSU, Rei KITAGAWA, Mayumi MIKAMI, Takeshi NAKAYAMA-KAMADA, Chie KURIBARA, Tomoyoshi HIRANO, Tsukasa ARIHARA, Masayasu MIKUNI, Nobuhiro Neurol Med Chir (Tokyo) Technical Note Several structures including subthalamic nucleus (STN), the caudal zona incerta (cZI), the prelemniscal radiation (Raprl), and the thalamic ventral intermediate nucleus (Vim) have been reported to be useful for improving symptoms of Parkinson’s disease (PD). However, the effect of each target is still unclear. Therefore, we investigated each structure’s effects and adverse effects using a directional lead implanted in the posterior STN adjacent to the cZI and Raprl in two patients with tremor-dominant PD. In Case 1, maximal reduction of tremor was obtained by stimulation toward the Vim, and stimulation toward the thalamic reticular nucleus (TRN) reduced verbal fluency, but did not induce dysarthria. In Case 2, maximal reduction of tremor was obtained by stimulation toward the dorsal STN and Raprl. Maximal reduction of rigidity was achieved by stimulation toward the dorsal STN, Raprl, and cZI. Bradykiensia was improved by stimulation in all directions, but dyskinesia and dysarthria were evoked by stimulation toward the dorsal STN and cZI. The directional lead may elucidate the stimulation effect of each structure and broaden target selection depending on patients’ symptoms and adverse effects. The Japan Neurosurgical Society 2020-12 2020-11-06 /pmc/articles/PMC7803701/ /pubmed/33162470 http://dx.doi.org/10.2176/nmc.tn.2020-0210 Text en © 2020 The Japan Neurosurgical Society This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Technical Note
SASAGAWA, Ayaka
ENATSU, Rei
KITAGAWA, Mayumi
MIKAMI, Takeshi
NAKAYAMA-KAMADA, Chie
KURIBARA, Tomoyoshi
HIRANO, Tsukasa
ARIHARA, Masayasu
MIKUNI, Nobuhiro
Target Selection of Directional Lead in Patients with Parkinson’s Disease
title Target Selection of Directional Lead in Patients with Parkinson’s Disease
title_full Target Selection of Directional Lead in Patients with Parkinson’s Disease
title_fullStr Target Selection of Directional Lead in Patients with Parkinson’s Disease
title_full_unstemmed Target Selection of Directional Lead in Patients with Parkinson’s Disease
title_short Target Selection of Directional Lead in Patients with Parkinson’s Disease
title_sort target selection of directional lead in patients with parkinson’s disease
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803701/
https://www.ncbi.nlm.nih.gov/pubmed/33162470
http://dx.doi.org/10.2176/nmc.tn.2020-0210
work_keys_str_mv AT sasagawaayaka targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT enatsurei targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT kitagawamayumi targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT mikamitakeshi targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT nakayamakamadachie targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT kuribaratomoyoshi targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT hiranotsukasa targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT ariharamasayasu targetselectionofdirectionalleadinpatientswithparkinsonsdisease
AT mikuninobuhiro targetselectionofdirectionalleadinpatientswithparkinsonsdisease